Athanasios Trikas

ORCID: 0000-0003-4367-805X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Atrial Fibrillation Management and Outcomes
  • Acute Myocardial Infarction Research
  • Lipoproteins and Cardiovascular Health
  • Cardiac Health and Mental Health
  • Cardiac Valve Diseases and Treatments
  • Cardiac Structural Anomalies and Repair
  • Heart Failure Treatment and Management
  • Cardiac tumors and thrombi
  • Cardiovascular Disease and Adiposity
  • Cardiac electrophysiology and arrhythmias
  • Cardiomyopathy and Myosin Studies
  • Cardiac Fibrosis and Remodeling
  • Cardiovascular Effects of Exercise
  • Viral Infections and Immunology Research
  • Coronary Interventions and Diagnostics
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Atherosclerosis and Cardiovascular Diseases
  • Heart Rate Variability and Autonomic Control
  • Coronary Artery Anomalies
  • Infective Endocarditis Diagnosis and Management
  • Aortic Disease and Treatment Approaches
  • Antiplatelet Therapy and Cardiovascular Diseases

Evangelismos Hospital
1996-2025

General Hospital of Athens Elpis
2013-2024

National and Kapodistrian University of Athens
1994-2022

Hippocration General Hospital
1994-2012

Athens State University
2005-2009

Hammersmith Hospital
2000-2004

Abstract Background Reports from countries severely hit by the COVID‐19 pandemic suggest a decline in acute coronary syndrome (ACS)‐related hospitalizations. The generalizability of this observation on ACS admissions and possible related causes with low incidence are not known. Hypothesis were reduced country spared COVID‐19. Methods We conducted nationwide study rates ACS‐related during 6‐week period outbreak corresponding control 2019 Greece, strict social measures, incidence, no excess...

10.1002/clc.23424 article EN cc-by Clinical Cardiology 2020-07-21

Percutaneous retrograde nontransseptal balloon mitral valvuloplasty is a new technique developed in our institution for opening stenotic valve. This based on new, externally steerable cardiac catheter that enters the left atrium retrogradely via ventricle.The was used 86 consecutive patients (18 men and 68 women; mean age, 51 +/- 11 years). Dilatation of valve achieved 85 patients. After procedure, area increased from 0.92 0.22 to 2.14 0.54 cm2 transmitral gradient decreased 16 6 5 2 mm Hg....

10.1161/01.cir.85.5.1760 article EN Circulation 1992-05-01

Abstract miR-27a-3p targets several proteins on the coagulation cascade. The potential effect of direct oral anticoagulants (DOACs) treatment expression and their broader regulative anticoagulation is unknown. Fifty-nine atrial fibrillation patients treated with rivaroxaban ( n = 19), apixaban 27) or dabigatran 13), were included in study. was analyzed at baseline after 7 days DOAC therapy by using a predesigned TaqMan assay. Relative quantitation calculated compared pooled population...

10.1007/s11239-025-03102-5 article EN cc-by Journal of Thrombosis and Thrombolysis 2025-04-21

Background: Thyroid hormone has a differential action on healthy and ischemic heart. Triiodothyronine (T3) administration improved postischemic cardiac function while it limited apoptosis in experimentally induced ischemia. Thus, the present study investigated potential effects of acute liothyronine (LT3) treatment patients with anterior myocardial infarction. Methods: This is pilot, randomized, double-blind, placebo-controlled trial (ThyRepair study). We randomized 52 analyzed data from 37...

10.1089/thy.2021.0596 article EN Thyroid 2022-03-17

Direct oral anticoagulants (DOACs) are the standard treatment for thromboembolic protection in atrial fibrillation (AF) patients. Epigenetic modifications, such as DNA methylation and microRNAs, have emerged potential biomarkers of AF. The epigenetics DOACs is still an understudied field. It largely unknown whether epigenetic modifications interfere with DOAC response or induces modifications. To fill this gap, we started miR-CRAFT (Circulating microRNAs regulators Oral Anticoagulant...

10.3390/jpm14060562 article EN Journal of Personalized Medicine 2024-05-24

Background Deceleration capacity (DC) of heart rate proved an independent mortality predictor in postmyocardial infarction patients. The original method (DCorig) may produce negative values (9% our analyzed sample). We aimed to improve the and investigate if DC also predicts arrhythmic mortality. Methods Time series from 221 failure patients was with DCorig a new variant, DCsgn, which decelerations are characterized based on windows four consecutive beats not anchors. After 41.2 months, 69...

10.1111/anec.12343 article EN Annals of Noninvasive Electrocardiology 2016-04-01

The aim of this study was to evaluate the differences in quality life and psychosocial stress parameters among patients with paroxysmal atrial fibrillation (AF) common forms atrioventricular reentry supraventricular tachycardias (SVTs).The total population included 106 patients, 54 AF (32 males, age 56.64±12.50 years) 52 SVTs (25 40.46±14.96 years). General health (p<0.01), physical function (p=0.004), role emotion (p=0.002) (p<0.01) scores were lower who suffered AF. SF-36 mental summary...

10.1016/s0972-6292(16)30796-3 article EN cc-by-nc-nd Indian Pacing and Electrophysiology Journal 2014-09-01

Thyroid hormone (TH) appears to have a reparative action on the postinfarcted myocardium. This novel was recently tested in pilot, randomized, double-blind, placebo-controlled trial (ThyRepair). The present study performed

10.3389/fendo.2024.1405251 article EN cc-by Frontiers in Endocrinology 2024-07-26

In this study, we both investigated coronary flow velocity in hypertrophic obstructive cardiomyopathy (HOCM) and tested the hypothesis of differing reserve (CFR) arteries perfusing left ventricular regions with nonuniform myocardial hypertrophy by measuring relative CFR.Coronary was assessed anterior descending (LAD) circumflex (LCX) 18 patients HOCM marked only septum, 13 without obstruction (HCM), 9 age- sex-matched normal subjects at rest, during rapid atrial pacing, after dobutamine...

10.1161/01.cir.96.3.834 article EN Circulation 1997-08-05
Coming Soon ...